France – Produits pharmaceutiques – Fourniture de médicaments des voies digestives et du métabolisme pour les Etablissements de santé de Bretagne - Relance n°2
AI summary
This tender concerns the supply of pharmaceutical products for digestive and metabolic disorders to healthcare establishments in Brittany, France. It covers three lots previously cancelled due to lack of suitable bids or public interest grounds. Supply is expected to commence 1 May 2026.
Pharmaceutical distributors, manufacturers, or qualified wholesalers with authorization to supply medicinal products to French healthcare institutions should bid.
Suppliers must be authorized pharmaceutical distributors or manufacturers capable of supplying medicinal products compliant with French and EU pharmaceutical regulations. Tenderers should demonstrate experience in healthcare facility supply chains.
Frequently asked questions
What is this tender about?
This tender concerns the supply of pharmaceutical products for digestive and metabolic disorders to healthcare establishments in Brittany, France. It covers three lots previously cancelled due to lack of suitable bids or public interest grounds. Supply is expected to commence 1 May 2026.
What are the requirements for suppliers?
Suppliers must be authorized pharmaceutical distributors or manufacturers capable of supplying medicinal products compliant with French and EU pharmaceutical regulations. Tenderers should demonstrate experience in healthcare facility supply chains.
What type of company should bid?
Pharmaceutical distributors, manufacturers, or qualified wholesalers with authorization to supply medicinal products to French healthcare institutions should bid.
Who is the buyer?
The buyer is Centre hospitalier Bretagne Atlantique.
When does this tender close?
Submissions close on April 27, 2026.
What is the estimated value?
The estimated value is 858,200 EUR.
Fourniture de médicaments des voies digestives et du métabolisme pour les Etablissements de santé de Bretagne - Relance n°2. Cette consultation concerne trois (3) lots ayant fait l’objet d’une décision de déclaration sans suite pour infructuosité ou pour motif d’intérêt général dans le cadre d’une consultation antérieure. Date prévisionnelle de commencement des prestations : 1er mai 2026
A02AX HYDROXYDE ALUMINIUM ET MAGNESIUM
Fourniture d'HYDROXYDE ALUMINIUM ET MAGNESIUM pour les Etablissements de santé de Bretagne. Les spécifications techniques de ce lot sont définies dans le cahier des clauses techniques particulières et son annexe 1, le Catalogue des besoins.
A04AA ONDANSETRON INJECTABLE
Fourniture d’ONDANSETRON INJECTABLE pour les Etablissements de santé de Bretagne. Les spécifications techniques de ce lot sont définies dans le cahier des clauses techniques particulières et son annexe 1, le Catalogue des besoins.
A12AX CALCIUM VITAMINE D3
Fourniture de CALCIUM VITAMINE D3 pour les Etablissements de santé de Bretagne. Les spécifications techniques de ce lot sont définies dans le cahier des clauses techniques particulières et son annexe 1, le Catalogue des besoins.
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…